Difference between revisions of "Pirarubicin (THP)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m |
m |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
''Approved for use in a number of countries; not the US.'' | ''Approved for use in a number of countries; not the US.'' | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
− | *[[ | + | *[[Diffuse large B-cell lymphoma]] |
+ | *[[Upper tract urothelial carcinoma]] | ||
==Also known as== | ==Also known as== | ||
Line 14: | Line 15: | ||
[[Category:Anthracyclines]] | [[Category:Anthracyclines]] | ||
− | [[Category: | + | [[Category:Diffuse large B-cell lymphoma medications]] |
+ | [[Category:Upper tract urothelial carcinoma medications]] |
Latest revision as of 19:37, 28 December 2023
Approved for use in a number of countries; not the US.
Diseases for which it is used
Also known as
- Code name: 1609-RB
- Generic name: theprubicin, THP-doxorubicin
- Brand names: Pinorubicin, Pinorubin, Therarubicin